
2019 US Investing champion Leif Soreide recently noted that certain biotechnology stocks tend to be unaffected by the ups and downs of the overall market, providing an opportunity for profitable trades even during challenging times. In this article, we’ll explore this concept by examining Moderna and Pfizer.